Pharmacological manipulation of central nitric oxide/guanylate cyclase activity alters Fos expression by rat hypothalamic vasopressinergic neurons during acute glucose deprivation

Journal of Chemical Neuroanatomy

Volumn 17, Issue 1, 1999, Pages 13-19

  Briski, Karen P ^a  

^a LOUISIANA STATE UNIVERSITY   (United States)

Author keywords

2 deoxy D glucose; Fos; Nitric oxide synthase; ODQ; Paraventricular nucleus; SIN1; Vasopressin

Indexed keywords

1H 1,2,4 OXADIAZOLO[4,3 A]QUINOXALIN 1 ONE; CYCLIC GMP; DEOXYGLUCOSE; GUANYLATE CYCLASE; LINSIDOMINE; NITRIC OXIDE; PROTEIN C FOS; VASOPRESSIN RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIET RESTRICTION; ENZYME ACTIVITY; HYPOTHALAMUS; IMMUNOHISTOCHEMISTRY; INTRACEREBRAL DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION;

ANIMALS; DEOXYGLUCOSE; ENZYME INHIBITORS; GLUCOSE; GUANYLATE CYCLASE; HYPOTHALAMUS; IMMUNOENZYME TECHNIQUES; MALE; MOLSIDOMINE; NEURONS; NITRIC OXIDE; NITRIC OXIDE DONORS; NITRIC OXIDE SYNTHASE; OXADIAZOLES; PROTO-ONCOGENE PROTEINS C-FOS; QUINOXALINES; RATS; RATS, SPRAGUE-DAWLEY; TRANSCRIPTION FACTOR AP-1; VASOPRESSINS;

EID: 0032868692     PISSN: 08910618     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0891-0618(99)00021-6     Document Type: Article

References (20)

1. Arevalo R., Sanchez F., Alonso J.R., Carretero J., Vasquez R., Aijon J. NADPH-diaphorase activity in the hypothalamic magnocellular neurosecretory nuclei of the rat. Brain Res. Bull. 28:1992;599-603.
2. Bhat G., Mahesh V.B., Aguan K., Brann D.W. Evidence that brain nitric oxide synthase is the major nitric oxide synthase isoform in the hypothalamus of the adult female rat and that nitric oxide potently regulates hypothalamic cGMP levels. Neuroendocrinology. 64:1996;93-102.
3. Bredt D.S., Snyder S.H. Isolation of nitric oxide synthase, a calmodulin-requiring enzyme. Proc. Natl. Acad. Sci. 87:1990;682-685.
4. Caraty A., Grino M., Locatelli A., Guillaume V., Bourdouresque F., Conte-Devoix B. et al. Insulin-induced hypoglycemia stimulates corticotropin-releasing factor and arginine vasopressin secretion into hypophyseal portal blood of conscious, unrestrained rams. J. Clin. Invest. 85:1990;1716-1721.
5. Chiodera P., Volpi R., Capretti L., Speroni G., Marcato A., Rossi G. et al. Hypoglycemia-induced arginine vasopressin and oxytocin release is mediated by glucoreceptors located inside the blood-brain barrier. Neuroendocrinology. 55:1992;655-659.
6. Chiodera P., Volpi R., Coiro V. Inhibitory control of nitric oxide on the arginine-vasopressin and oxytocin response to hypoglycemia in normal men. NeuroReport. 5:1994;1822-1824.
7. Engler D., Pham T., Fullerton M.J., Ooi G., Funder J.W., Clarke I.J. Studies of the secretion of corticotropin-releasing factor and arginine vasopressin into the hypophyseal-portal circulation of the conscious sheep. Neuroendocrinology. 49:1989;367-381.
8. Fedele E., Conti A., Raiteri M. The glutamate receptor/NO/cyclic GMP pathway in the hippocampus of freely moving rats: modulation by cyclothiazide, interaction with GABA and the behavioral consequences. Neuropharmacology. 36:1997;1393-1403.
9. Hrabovszky E., Vrontakis M.E., Petersen S.L. Triple-labeling method combining immunocytochemistry and in situ hybridization histochemistry: demonstration of overlap between Fos-immunoreactive and galanin mRNA-expressing subpopulations of luteinizing hormone-releasing hormone neurons in female rats. J. Histo. Cyto. 43:1995;363-370.
10. Kadekaro M., Liu H., Terrell M.L., Gestl S., Bui V., Summy-Long J.Y. Role of NO on vasopressin and oxytocin release and blood pressure responses during osmotic stimulation in rats. Am. J. Physiol. 273:1997;R1024-1030.
11. Kadowski K., Kishimoto J., Leng G., Emson P.C. Up-regulation of nitric oxide synthase (NOS) gene expression together with NOS activity in the rat hypothamo-hypophysial system after chronic salt loading: evidence of a neuromodulatory role of nitric oxide in arginine vasopressin and oxytocin secretion. Endocrinology. 134:1994;1011-1017.
12. Miyagawa A., Okamura H., Ibata Y. Coexistence of oxytocin and NADPH-diaphorase in magnocellular neurons of the paraventricular and the supraoptic nuclei of the rat hypothalamus. Neurosci. Lett. 171:1994;13-16.
13. Morgan J.I., Curran T. Stimulus-transcription coupling in the nervous system: involvement of the inducible proto-oncogenes fos and jun. Annu. Rev. Neurosci. 14:1991;421-451.
14. Nagai N., Nagai K., Takezawa K., Chun S.J., Nakagawa H. Suppressive effect of vasopressin on the hyperglycemic response to intracranial injection of 2-deoxy-D-glucose. Neurosci. Lett. 190:1995;187-190.
15. Nussey S.S., Ang V.T., Finer N., Jenkins J.S. Responses of neurohypophyseal peptides to hypertonic saline and insulin-induced hypoglycemia in man. Clin. Endocrinol. 24:1986;97-105.
16. Ritter S., Dinh T.T. 2-mercaptoacetate and 2-deoxy-D-glucose induce Fos-like immunoreacticity in rat brain. Brain Res. 641:1994;111-120.
17. Sagar S.M., Ferriero D.M. NADPH diaphorase activity in the posterior pituitary: relation to neuronal function. Brain Res. 400:1987;348-352.
18. Tassorelli C., Joseph S.A. NADPH-diaphorase activity and Fos expression in brain nuclei following nitroglycerin administration. Brain Research. 695:1995;34-44.
19. Uemura K., Tamagawa T., Chen Y., Maeda N., Yoshioka S., Itoh K. et al. N-g-methyl-L-arginine, an inhibitor of nitric oxide synthase, affects the central nervous system to produce peripheral hyperglycemia in conscious rats. Neuroendocrinology. 66:1997;136-144.
20. Yokotani K., Murakami Y., Okuma Y., Osumi Y. Centrally applied nitric oxide donors inhibit vagally evoked rat gastric acid secretion: involvement of sympathetic outflow. Jpn. J. Pharmacol. 74:1997;337-340.